Hangzhou Coco Healthcare ProductsLtd Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Liwei Jin
Chief executive officer
CN¥1.5m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | 30.7% |
| Management average tenure | no data |
| Board average tenure | less than a year |
Recent management updates
Recent updates
Subdued Growth No Barrier To Hangzhou Coco Healthcare Products Co.,Ltd. (SZSE:301009) With Shares Advancing 38%
Dec 16
What You Can Learn From Hangzhou Coco Healthcare Products Co.,Ltd.'s (SZSE:301009) P/S
Sep 29Why Hangzhou Coco Healthcare ProductsLtd's (SZSE:301009) Earnings Are Better Than They Seem
May 03Hangzhou Coco Healthcare Products Co.,Ltd. (SZSE:301009) Doing What It Can To Lift Shares
Apr 16CEO
Liwei Jin (54 yo)
less than a year
Tenure
CN¥1,502,300
Compensation
Mr. Liwei Jin serves as Chairman of the Board since August 28, 2011 and General Manager since January 19, 2024 at Hangzhou Coco Healthcare Products Co.,Ltd.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & CEO | 13.4yrs | CN¥1.50m | 30.74% CN¥ 887.1m | |
| Independent Director | less than a year | no data | no data | |
| Supervisor | 13.4yrs | no data | no data | |
| Non-Independent Director | less than a year | CN¥1.21m | 29.72% CN¥ 857.6m | |
| Independent Director | less than a year | no data | no data |
1.0yrs
Average Tenure
43yo
Average Age
Experienced Board: 301009's board of directors are not considered experienced ( 1 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/02 23:11 |
| End of Day Share Price | 2025/01/02 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Hangzhou Coco Healthcare Products Co.,Ltd. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Chen He | Chasing Securities |
| Sun-Hai Yang | Tianfeng Securities Brokerage Co., Ltd |